Lerociclib plus fulvestrant in patients with HR+/HER2- locally advanced or metastatic breast cancer who have progressed on prior endocrine therapy: LEONARDA-1 a phase III randomized trial
在既往接受过内分泌治疗后病情进展的HR+/HER2-局部晚期或转移性乳腺癌患者中,Lerociclib联合氟维司群的疗效:LEONARDA-1 III期随机试验
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-56096-2
Xu, Binghe; Zhang, Qingyuan; Luo, Yang; Tong, Zhongsheng; Sun, Tao; Shan, Changping; Liu, Xinlan; Yao, Yumin; Zhao, Bing; Wang, Shusen; Zeng, Xiaohua; Hu, Changlu; Yan, Xi; Wang, Xiaojia; Jia, Hongyan; Chen, Zhendong; Qiu, Fuming; Wu, Xinhong; Zhang, Deyong; Li, Tong